Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Pharma

Healthcare companies see tech partnerships as necessary to implement smart technologies, according to a survey by GlobalData

As pharma companies continue to scale up digital transformation processes, a survey by GlobalData has highlighted that teaming up with experienced external vendors is driving innovative technology implementation. The leading data and analytics company notes that technologies such as 5G, IoT, sensors, blockchain, cloud and virtual/augmented reality were the top technologies for which pharma companies used […]
Read more

Novo Nordisk’s Ozempic digital marketing in Australia can be exemplar for other players in type 2 diabetes space, says GlobalData

The type 2 diabetes (T2D) treatment landscape in Australia is mature with the availability of generics, insulin biosimilars and novel therapies. In this competitive market, pharma digital marketing is minimal. However, Novo Nordisk has successfully implemented a digital strategy for its newly launched drug Ozempic (July 2020) and can be an exemplar for other leading […]
Read more

AI and big data will continue to disrupt pharmaceutical sector, according to healthcare industry professionals surveyed by GlobalData

Artificial intelligence (AI) and big data will play a major role in optimizing pharmaceutical drug discovery and development process, as indicated by 24% and 25% of global healthcare industry professionals, respectively 23% of the surveyed healthcare industry professionals confirmed that their companies were currently using in AI to enhance drug discovery and development process with […]
Read more

ADA Update of the BCG vaccine shows potential to out-compete more expensive pipeline immunotherapies for T1D, says GlobalData

Following the ADA update of the bacillus Calmette-Guerin (BCG) vaccine as a treatment for type 1 diabetes (T1D) earlier this month, leading data and analytics company GlobalData notes that BCG is well positioned as a repurposed drug to out-compete more expensive pipeline immunotherapy options if further studies continue to demonstrate similar efficacy results. Samisha Khangaonkar, […]
Read more

2021 is a pivotal year for field of personalized neoantigen immuno-oncology therapeutics, says GlobalData

New immunotherapy agents in the oncology pipeline aim to predict the most important tumor antigens and formulate a personalized vaccine against them. With multiple catalysts coming up in Q4 2021, data from a number of early-stage biotech companies will have a profound impact on the industry’s sentiment regarding personalized neoantigen therapeutics, according to GlobalData, a […]
Read more

COVID-19 vaccine market set to reach $19.5bn by 2026

The size of the COVID-19 vaccine market across the seven major markets (7MM*) will increase from $13.6bn in 2021 to $19.5bn in 2026 at a compound annual growth rate (CAGR) of 7.6% should annual vaccination be required, according to GlobalData, a leading data and analytics company. COVID-19 vaccines based on mRNA technology dominate the 7MM […]
Read more

Seelos Therapeutics’ SLS-002 could be a strong competitior to Spravato for treatment of suicidal behavior, says GlobalData

Seelos Therapeutics has recently announced that the first patient has been dosed in the second part of its registrational study of SLS-002 (intranasal racemic ketamine) for acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD). If approved SLS-002 would become only the second product approved specifically for ASIB, after Johnson & […]
Read more

Migraine digital marketing space in Japan can evolve with launch of Amgen, Teva CGRP inhibitors, says GlobalData

The migraine treatment landscape in Japan is growing with the recent approval of calcitonin gene-related peptide (CGRP) inhibitors as preventative treatment. In this developing market, digital activity has not been prominent until now. However, it is expected to evolve with the recent approval of Amgen and Teva’s drugs, says GlobalData, a leading data and analytics […]
Read more

Sales of long-acting immunosuppressants for non-infectious uveitis will quadruple to reach $357m by 2029, says GlobalData

Corticosteroids are typically the first line of therapy for most patients with uveitis as these drugs are very effective and have anti-inflammatory effects. However, as corticosteroids are associated with the development of cataracts and changes in intraocular pressures, it is becoming increasingly common for other immunosuppressants such as antimetabolites and calcineurin inhibitors to be prescribed […]
Read more

Opportunities remain for drug developers to address unmet needs in cystic fibrosis therapeutics market, says GlobalData

Over the past decade, disease-modifying cystic fibrosis transmembrane conductance regulator (CFTR) modulators have transformed the treatment paradigm for CF, according to GlobalData, greatly improving the quality of life and longevity of patients. The leading data and analytics company notes that this drug class has grown rapidly since 2012 with up to four different agents. In […]
Read more
1 … 59 60 61 62 63 … 108